Cangrelor-to-Prasugrel Switches in Patients Undergoing PCIs
Testing for the possibility of a drug-drug interaction (DDI) in patients undergoing percutaneous coronary intervention (PCI), investigators found that “concomitant administration of prasugrel with cangrelor